1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Intracranial Hypertension Global Clinical Trials Review, H2, 2014

Intracranial Hypertension Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracranial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracranial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Intracranial Hypertension Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Intracranial Hypertension 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Intracranial Hypertension 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Drugs 26
Clinical Trial Overview of Top Institutes / Government 27
University Hospital, Grenoble 27
Clinical Trial Overview of University Hospital, Grenoble 27
Duke University 28
Clinical Trial Overview of Duke University 28
North Bristol NHS Trust 29
Clinical Trial Overview of North Bristol NHS Trust 29
Institut d'Anesthesiologie des Alpes Maritimes 30
Clinical Trial Overview of Institut d'Anesthesiologie des Alpes Maritimes 30
University of Cincinnati 31
Clinical Trial Overview of University of Cincinnati 31
Chang Gung Memorial Foundation 32
Clinical Trial Overview of Chang Gung Memorial Foundation 32
University of Colorado 33
Clinical Trial Overview of University of Colorado 33
University of Texas Health Science Center at San Antonio 34
Clinical Trial Overview of University of Texas Health Science Center at San Antonio 34
University Hospital, Bordeaux 35
Clinical Trial Overview of University Hospital, Bordeaux 35
Hospices Civils de Lyon 36
Clinical Trial Overview of Hospices Civils de Lyon 36
Five Key Clinical Profiles 37
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Region, 2014* 6
Intracranial Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Intracranial Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Intracranial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Intracranial Hypertension Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Intracranial Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Intracranial Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Intracranial Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Intracranial Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Intracranial Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Intracranial Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Intracranial Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Intracranial Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Intracranial Hypertension Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Intracranial Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Intracranial Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Intracranial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Intracranial Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Intracranial Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014* 27
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 28
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by North Bristol NHS Trust, 2014* 29
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut d'Anesthesiologie des Alpes Maritimes, 2014* 30
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 31
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 32
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014* 33
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Health Science Center at San Antonio, 2014* 34
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 35
Intracranial Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2014* 36

List of Figures
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Intracranial Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Intracranial Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Intracranial Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Intracranial Hypertension Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Intracranial Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Intracranial Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Intracranial Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Intracranial Hypertension to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Intracranial Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Intracranial Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Intracranial Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Intracranial Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Intracranial Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Intracranial Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Intracranial Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 56

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.